F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

Health Consultant October 30, 2025 0

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.

from NYT > Health https://ift.tt/blQEIcz
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )